Archive - July 2020
Biogen plans Spinraza study in SMA patients treated with Novartis’ Zolgensma
Genfit scraps phase 3 trial of experimental NASH drug
AZ’ COPD therapy wins US approval
PharmaTimes competitions go virtual!
Roche cites COVID-19 and biosimilars in Q2 decline
BioMarin submits EU marketing application for vosoritide
Gov unveils plans to boost UK’s vaccines manufacturing capabilities
Lords urge government to act to now avert winter COVID-19 spike